Perspective
Mar. 7, 2013
Securities fraud plaintiffs need not prove materiality at class certification stage
Although the court's decision in Amgen is interesting, its significance remains to be seen. By Eric S. Waxman and Virginia Milstead
In a case closely watched by the federal securities class action bar, Amgen, Inc. v. Connecticut Retirement Plans and Trust Funds, 2013 DJDAR 2521 (Feb. 27, 2013), the U.S. Supreme Court held that for purposes of seeking certification of a class asserting claims under Section 10(b) and Rule 10b-5 of the Securities Exchange Act, a plaintiff need not prove the materiality of alleged misleading statements ...
To continue reading, please subscribe.
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
For only $95 a month (the price of 2 article purchases)
Receive unlimited article access and full access to our archives,
Daily Appellate Report, award winning columns, and our
Verdicts and Settlements.
Or
$895, but save $100 when you subscribe today… Just $795 for the first year!
Or access this article for $45
(Purchase provides 7-day access to this article. Printing, posting or downloading is not allowed.)
Already a subscriber?
Sign In